With an increasing number of women getting cosmetic breast surgeries done at civic hospitals in Mumbai, Parel’s KEM Hospital is holding a day-long workshop on ‘aesthetic breast surgery’ for its doctors. Experts will conduct four live breast surgeries to offer exposure to post-graduate medical students and about 70 other plastic surgeons from across the country. The four live surgeries which will be conducted as part of the workshop.

Read the full story here

Following a review of topical formulations of ketoprofen, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefit-risk balance of these medicines continues to be positive. However, the Committee recommended that doctors should inform patients on how to use these medicines appropriately. Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID). Topical formulations of ketoprofen are used to treat minor trauma, tendonitis, small-joint osteoarthritis, acute low-back pain and phlebitis.

Read the full story here

AmStem Corporation announced positive early results from its preliminary consumer study of SteMixx™. Full study results will be available at the end of this month. AmStem has engaged a labeling consultant for their flagship SteMixx™ product to make it available for retail consumer use as soon as possible in the U.S. AmStem has finalized its submission to an independent Institutional Review Board (IRB) to begin the first clinical trial of SteMixx in the United States.

Read the full story here

Nitric BioTherapeutics, Inc. announced the initiation of a Phase II clinical trial of the company’s proprietary drug/device combination, which delivers terbinafine via the process of iontophoresis for the treatment of onychomycosis. Onychomycosis is commonly known as toenail fungus. Nitric Bio’s proprietary drug/device combination delivers very high doses of a unique formulation of terbinafine, the most effective medication used to treat onychomycosis, directly to the site of the infection – on, around and under the toenail.

Read the full story here

Women seek breast augmentation surgery for a variety of reasons–for a fuller figure, for a more youthful breast shape, and sometimes to even out the size of their breasts. Uneven breasts are fairly normal. In fact most women have one breast that is at least slightly larger than the other. However, for women with noticeably uneven breasts, breast augmentation surgery can be a great solution for bringing them into balance.

Read the full story here.

Dermal fillers are often confused with Botox, and though both are delivered by injection, they serve very different purposes. As the name implies, fillers are designed to plump wrinkles, fill in hollowness and enhance lips, while Botox targets and relaxes muscles to prevent new lines from developing. The advantages of fillers outweigh the risks, according to experts such as Dr. Neal Schultz of DermTV.com. Fillers are generally cost-effective (starting at a few hundred dollars), easy to administer and natural looking. Schultz says. The effects generally last four to 12 months. The risks? Fillers can cause occasional bruising, mild pain or discomfort when injected and, in rare circumstances, allergic reactions.

Read the full story here.

E. Fougera & Co has received first generic approval from the FDA for Adapalene Cream 0.1% (Rx) for the treatment of acne vulgaris. Fougera’s Adapalene Cream 0.1% is rated AB, generically equivalent to Differin® by Galderma Pharmaceuticals. According to industry data, U.S. sales of the brand named product in 2009 exceeded $55 million. This approval also marks the fourth product approval that the FDA has granted to Fougera this year.

Mesynthes has introduced a tissue substitute for people suffering from tissue damage, burns and reconstructive surgeries. The company’s Endoform Dermal Template is an FDA approved ready-to-use tissue substitute that can be used for wound care and dermal reconstruction. The product will improve the rate and quality of healing. Mesynthes is also developing Endoform Infection Control for the prevention of infection if there is a high risk of post-operative infection.